Protalix BioTherapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Oct 23 | BuyUS$90,484 | Dror Bashan | Individual | 64,516 | US$1.41 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,397,263 | 3.27% |
Hedge Funds | 8,137,181 | 11.1% |
Individual Insiders | 8,269,526 | 11.3% |
Institutions | 10,288,090 | 14% |
General Public | 44,224,024 | 60.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,137,181 | US$9.4m | 0% | 0.39% | |||
4,676,341 | US$5.4m | 97.9% | no data | |||
3,457,734 | US$4.0m | 8.89% | no data | |||
2,385,331 | US$2.8m | 0% | no data | |||
2,281,934 | US$2.6m | 13.1% | no data | |||
826,581 | US$958.8k | 8.76% | no data | |||
724,575 | US$840.5k | 3.48% | no data | |||
665,600 | US$772.1k | 7.16% | no data | |||
570,000 | US$661.2k | 0% | no data | |||
544,238 | US$631.3k | 9.55% | 0.06% | |||
494,237 | US$573.3k | 21.6% | no data | |||
302,686 | US$351.1k | 7.57% | no data | |||
262,081 | US$304.0k | 0% | no data | |||
237,012 | US$274.9k | 0% | no data | |||
208,790 | US$242.2k | 31.5% | no data | |||
207,299 | US$240.5k | -0.3% | no data | |||
205,937 | US$238.9k | 0% | 0.04% | |||
203,079 | US$235.6k | 17.1% | no data | |||
174,000 | US$201.8k | 0% | no data | |||
173,206 | US$200.9k | -2.96% | no data | |||
167,020 | US$193.7k | 68.4% | no data | |||
153,561 | US$178.1k | 0% | no data | |||
130,000 | US$150.8k | 44.4% | 0.58% | |||
125,702 | US$145.8k | 170% | no data | |||
120,000 | US$139.2k | 0% | 0.32% |